[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343935-105":59,"doc-detail-343935-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pan-cancer-analysis-of-homologous-recombination-deficiency-in-cell-lines","Pan-Cancer Analysis of Homologous Recombination Deficiency in Cell Lines","","Homologous recombination deficiency (HRD) drives genomic instability across multiple cancer types and increases vulnerability to DNA-damaging therapies such as PARP inhibitors. In silico HRD prediction methods exist, yet few have been applied broadly to cell lines. Using “Classifier of HOmologous Recombination Deficiency” and “HRDsum,” the study predicts HRD in 1,332 cancer cell lines plus 84 noncancerous lines, validating strongest signals in BRCA1/2 biallelic mutants while identifying some BRCA1/2 wild-type HRD cases linked to epigenetic silencing.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-analysis-of-homologous-recombination-deficiency-in-cell-lines/343935/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-of-homologous-recombination-deficiency-in-cell-lines/343935.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How did the study predict homologous recombination deficiency (HRD) in cell lines?","Question",{"text":112,"@type":113},"It used two in silico methods, “Classifier of HOmologous Recombination Deficiency” and “HRDsum,” to score HRD across 1,332 cancer cell lines and 84 noncancerous cell lines.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which cell lines showed the strongest HRD predictions, and what does that validate?",{"text":117,"@type":113},"Cell lines with biallelic BRCA1 or BRCA2 mutations showed the strongest HRD predictions, validating both computational methods for HRD detection in cell lines.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical-pattern associations were observed for HRD in cell lines?",{"text":121,"@type":113},"HRD in cell lines associated with p53 loss, was mutually exclusive with microsatellite instability, and occurred most frequently in breast and ovarian cancer types.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343935,1790131896,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","RESEARCH ARTICLE  [https://doi.org/10.1158/2767-9764.CRC-24-0316](https://doi.org/10.1158/2767-9764.CRC-24-0316)  OPEN ACCESS  \nPan-Cancer Analysis of Homologous Recombination Deficiency in Cell Lines  \nAnne E. Dodson, Sol Shenker, Pamela Sullivan, Sumeet U. Nayak, Chris Middleton, Michael McGuire,  \nEdmond Chipumuro, Yuji Mishina, Erica R. Tobin, Louise Cadzow, Andrew A. Wylie, and Dipen Sangurdekar  \n􀀶  \nABSTRACT  \nHomologous recombination deficiency (HRD) drives genomic instability in multiple cancer types and renders tumors vulnerable to certain DNAdamaging agents such as PARP inhibitors. Thus, HRD is emerging as an attractive biomarker in oncology. A variety of in silico methods are available for predicting HRD; however, few of these methods have been applied to cell lines in a comprehensive manner. Here, we utilized two of these methods, “Classifier of HOmologous Recombination Deficiency”and “HRDsum” scores, to predict HRD for 1,332 cancer cell lines and 84 noncancerous cell lines. Cell lines with biallelic mutations in BRCA1 or BRCA2, which encode key components of the homologous recombination pathway, showed the strongest HRD predictions, validating the two methods in cell lines. A small subset of BRCA1/2 wild-type cell lines was also classified as HRD, several of which showed evidence of epigenetic BRCA1 silencing. Similar to HRD in patient samples, HRD in cell lines was associated with p53 loss, was mutually exclusive with  \nmicrosatellite instability, and occurred most frequently in breast and ovarian cancer types. In addition to validating previously identified associations with HRD, we leveraged cell line–specific datasets to gain new insights into HRD and its relation to various genetic dependency and drug sensitivity profiles. We found that in cell lines, HRD was associated with sensitivity to PARP inhibition in breast cancer but not at a pancancer level. By generating large-scale, pan-cancer datasets on HRD predictions in cell lines, we aim to facilitate efforts to improve our understanding of HRD and its utility as a biomarker.  \nSignificance: HRD is common in cancer and can be exploited therapeutically, as it sensitizes cells to DNA-damaging agents. Here, we scored more than 1,300 cancer cell lines for HRD using two different bioinformatic approaches, thereby enabling large-scale analyses that provide insights into the etiology and features of HRD.  \nIntroduction  \nHomologous recombination (HR) is a high-fidelity mechanism for the repair of DNA double-strand breaks. In the absence of HR, cells rely on more error-prone pathways such as polymerase θ–mediated end joining to repair double-strand breaks and thereby accumulate specific types of mutations over time ( 1) . The genomic instability that develops in response to HR deficiency (HRD) can, in turn, drive tumorigenesis. HRD is present in up to half of all high-grade serous ovarian cancers, at least a quarter of primary breast cancers, and a subset of pancreatic and prostate cancers (2–4) . As a source of genomic instability, HRD also sensitizes cells to certain types of DNA damage. Inhibition of PARP leads to an accumulation of DNA lesions that are insufficiently repaired in the absence of BRCA1 or BRCA2, key  \nKSQ Therapeutics, Lexington, Massachusetts  \nCorresponding Author: Dipen Sangurdekar, KSQ Therapeutics, 4 Maguire Road,  \nLexington, MA 02421. E-mail: [DSangurdekar@ksqtx.com](DSangurdekar@ksqtx.com)  \n[doi:](doi: 10.1158/2767-9764)[ 10.1158/2767-9764](doi: 10.1158/2767-9764) .CRC-24-0316  \nThis open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.  \n©2024 The Authors; Published by the American Association for Cancer Research  \ncomponents of the HR pathway (5, 6) . As a result, PARP inhibition leads to cell death in BRCA1/2-deficient tumors.  \nDue to its prevalence in cancer, HRD has garnered much interest from a clinical perspective, and several methods have been developed to detect HRD (7) .","cbCaiu2c96M609jz","https://ap.wps.com/l/cbCaiu2c96M609jz","pdf",8196311,15,"English","# Abstract\n# Introduction\n# Genomic Scar–Based HRD Predictions in Cancer Cell Lines","[{\"question\":\"How did the study predict homologous recombination deficiency (HRD) in cell lines?\",\"answer\":\"It used two in silico methods, “Classifier of HOmologous Recombination Deficiency” and “HRDsum,” to score HRD across 1,332 cancer cell lines and 84 noncancerous cell lines.\"},{\"question\":\"Which cell lines showed the strongest HRD predictions, and what does that validate?\",\"answer\":\"Cell lines with biallelic BRCA1 or BRCA2 mutations showed the strongest HRD predictions, validating both computational methods for HRD detection in cell lines.\"},{\"question\":\"What clinical-pattern associations were observed for HRD in cell lines?\",\"answer\":\"HRD in cell lines associated with p53 loss, was mutually exclusive with microsatellite instability, and occurred most frequently in breast and ovarian cancer types.\"}]","Pan-Cancer Analysis of Homologous Recombination Deficiency in Cell Lines | PDF",1790052526,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77d64267a4c8e7b3808a33388efe4a24.webp",983,1263,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30f121f2804c445687fef3ed6f9e009f.webp",982,1262,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebcbaa3e2f3b66a5082d517c99d89430.webp",981,1261,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ef25fd7afd46fb2258417bddbeb0d28.webp",980,1259]